Eli Lilly and Co (NYSE:LLY)
| 144.02 Delayed Data As of Dec 03 |  -0.09 / -0.06%Today’s Change | 115.92 Today|||52-Week Range 170.75 | +9.58% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 144.11 |
| Today’s open | 146.00 |
| Day’s range | 143.15 - 146.49 |
| Volume | 300 |
| Average volume (3 months) | 3,740,307 |
| Market cap | $141.0B |
Data as of 3:59pm ET, 12/03/2020
Growth & Valuation
| Earnings growth (last year) | +58.64% |
| Earnings growth (this year) | +18.46% |
| Earnings growth (next 5 years) | +13.20% |
| Revenue growth (last year) | -9.11% |
| P/E ratio | 23.6 |
| Price/Sales | 5.51 |
| Price/Book | 54.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.61 | -1.14% |
| BMYBristol-Myers Squibb | -0.40 | -0.64% |
| SNYSanofi | -0.51 | -1.01% |
| NVONovo Nordisk | +0.02 | +0.03% |
Data as of 7:50pm ET, 12/03/2020
Financials
| Next reporting date | January 29, 2021 |
| EPS forecast (this quarter) | $2.03 |
| Annual revenue (last year) | $22.3B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 20.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
